Lipid Sciences Completes Study in SIV-Infected Non-Human Primates
9th Sep 2005, 15:03 GMT
Lipid Sciences has completed its exploratory investigation of the therapeutic effect of delipidated autologous virus in chronically SIV-infected rhesus macaques.
Latest news from Operations-Related News from myHealthcareNews.com:
- Senior Housing Properties Trust Announces Proposed Public Offering of 5 mln Common Shares
- King Not Loving Its Shareholders
- Sepracor says asthma drug data is favorable
- Sepracor Presents Data on Asthma Drug
- Dr Reddy's Registers to List Shares
- PolyMedica Corp CEO to Ring the NASDAQ Stock Market Opening Bell
- Biovail to Present at the CSFB 2006 Healthcare Conference
- Genelabs reports lower Q3 loss
- Solexa posts narrowed Q3 loss
- Abbott's Humira Positive in 2 Studies